Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just the start, huge run-up prior to FDA decision. THis is CTIC all over again.
What a huge contract, this is fantastic.
This will explode today, this contract is HUGGEEE
From MCET's website:
MultiCell’s drug candidate, MCT-465 is a Toll-like Receptor (TLR) agonist, and is indicated as a prospective adjuvant therapy for the treatment of virus infections. MCT-465 is designed to exploit the body’s ability to recognize generic molecules related to pathogens. In preclinical studies, originally published in the Journal of Clinical Investigation, MCT-465 reduced pulmonary influenza A H1N1 virus titers by 1,000-fold in mouse models, resulting in barely detectable levels of the virus, illustrated in the figure below. The results suggest MCT-465 may also be able to reduce influenza A H5N1 viral load, also known as the “bird flu” or “avian flu” virus. The H5N1 strain of influenza A virus is genetically similar to the H1N1 strain of influenza A virus. MultiCell is planning further preclinical studies to determine the effectiveness of MCT-465 as an adjuvant therapy for the treatment of influenza A virus infection.
ALERT - MCET is a swine flu play wow
Pre-Clinical Mouse Models Show 1,000-fold Reduction in Viral Load in H1N1 Strain
LINCOLN, R.I.--(BUSINESS WIRE)--Oct. 21, 2005--MultiCell Technologies, Inc. (OTCBB: MCET - News) announced today that pre-clinical tests conducted by scientists at MultiCell's San Diego laboratories showed that MultiCell Immunotherapeutics, Inc.'s (MCTI's) toll receptor technology was able to reduce pulmonary virus titers by 1,000- fold in the H1N1 strain of flu to barely detectable levels. These results indicate that the technology may be able to reduce viral load in avian influenza. The H5N1 avian flu contains many of the same proteins as the H1N1 strain of flu, so the HINI results are projected to be important to the understanding of developing an immunotherapeutic against avian flu.
ADVERTISEMENT
MCTI's toll receptor technology employs double stranded RNA (dsRNA) and targets toll receptors 3,7 and 8. In studies of mouse models, the viral load was reduced by more than 90%. The results of the study showed that more than 100,000 units of pulmonary viral titers were reduced to negligible levels after administration of the immunotherapeutic. The Company plans additional pre-clinical trials to further evaluate the methodology and plans to approach the Centers for Disease Control and Prevention to conduct further studies. MultiCell acquired the technology as a result of its acquisition last month of substantially all of the assets of Astral, Inc.
"The pre-clinical results in mouse models support our view that our toll receptor technology may be able to respond to threats posed by agents such as avian influenza. We believe that these results highlight the commercial opportunities for our immunotherapeutics," said Dr. Stephen Chang, President of MultiCell Technologies Inc. "The recent acquisition of the assets of Astral has broadened our intellectual property platform considerably, and provides us with additional promising therapeutic opportunities."
Give it some time - once the penny flippers are done, it will explode. News IS GREAT.
The run has just started, this news will spread and you will see a buing frenzy. This stock could go up 1000% easily. It is MAJOR news.
The next upleg will be "brutal". Fasten ur seatbelts. I am in BIG.
Heading MUCH higher, this news is really huge. Pennyland coming soon.
My oph my, this is BIG
Just saw the news - this is HUGE news. This market is RED HOT. THis thing will explode.
Huge volume, kkaaaaboooooommmm coming eom
I expect a huge run this week; Target: 0.25 eom
This stock is DIRT cheap with yest. news.
The shorts are trapped and esperate, this short squeeze will be a sight to behold.
Volume coming in, it will explode since this thing is DIRT cheap here.
This thing is dirt cheap here, this one will blow very soon.
How mnay shares are outstanding?
This one is about to explode. Stock was 10+., incredible
HUGE numbers out, my oh my.
how many s/o pls? thanks
up 21 % today, much more to come. Market cap is only 200 k.
By far the cheapest flu stock out there (market cap is only 200 k)
"GeneThera's PURIVAX(TM), is a multi-resin anion exchange chromatography system that dramatically improves biological purity and viral titer of recombinant Adenovirus and AAV vectors. PURIVAX(TM), completely eliminates toxic side effects associated with adenoviruses and AAV vectors thereby making it possible to quickly develop highly immunogenic and safe recombinant DNA vaccines, which are significantly more efficacious in fighting today's bacterial and viral diseases like Bird Flu, as well as food pathogen applications."
Stock price scenarios??
Can we speculate a bit: what kind of numbers are you expecting? What are different scenarios for numbers and sp? Any guesses? Thanks and good luck.
How many shares are there outstanding right now pls? thanks
When I buy today, will I get the new shares or is it too late??
what do u mean exactly? thanks
DId NSTR pay 2 bucks per share? If yes, why should one buy NSTR NOW??
Yesterday's numbers (shale gas) were mind-boggling. This is huge steal here.
These numbers are mind-boggling: "Reserve estimates indicate a conservative gas in place value of 3.198 bcfg/mi.2 for the area under the Cumberland Plateau. These calculations assume a gas content of 20 scf/ton of gas in the Chattanooga Shale. Miller Petroleum, Inc. is in possession of geochemical data that justifies this as a minimal gas in place number."
OT GTHR.PK - biotech with a market cap of ... 175 k. Up 150% yesterday.
This is gonna be big, VERY big.
Going MUCH higher
Yep, even 10 cents is possible with the right kind of news
Even at a penny, market cap would be a tiny 970 k !!!!
Market cap right now only ... 200 k. We have a MONSTER here, mark my words. Should be a 100 bagger if this R/M thing is true.
What? ONLY 97 million - my oh my, this thing could go SKY high.
If this R/M deal is true, then look out above. Looks like news is leaking.
Yep, could be a 10-100 bagger from here.
Yup, huge winner at hand. This thing is a steal here, very low float. Rumor of a R/M with a very profitable private co that wants to go pucblic.